ClinicalTrials.Veeva

Menu

Tear Film Break-up Time After Instillation of Artificial Tears

C

Calm Water Therapeutics

Status

Completed

Conditions

Keratoconjunctivitis Sicca

Treatments

Drug: polyethylene glycol 400/propylene glycol
Drug: glycerin

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

This study is an exploratory trial evaluating the tear film break-up time after a single eye drop instillation of over-the-counter artificial tears. The primary hypothesis is that tear film break up time will be greater for test than control eye.

Full description

Subjects with varying degrees of dry eye syndrome were enrolled in a randomized, controlled, double masked, single site study. A new formulation of an artificial tear containing glycerin 1% as an active with polylysine-graft-polyethylene glycol as an excipient was compared against a leading commercial product with propylene glycol (0.3%) and polyethylene glycol (0.4%) as active ingredients with hydroxypropyl-guar as a gelling agent. The primary outcome was a comparison of tear film stability after eye drop instillation.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • symptoms of dry eye
  • no other history of ophthalmic problems

Exclusion criteria

  • Use of any ocular lubricant or ointment in the past 36 hours
  • use of contact lenses or excessive eye lid cosmetics on the study day

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

16 participants in 2 patient groups

glycerin
Experimental group
Description:
One eye will randomly receive a single instillation of one drop of a new formulation of an artificial tear containing glycerin 1% as an active with polylysine-graft-polyethylene glycol as an excipient.
Treatment:
Drug: glycerin
polyethylene glycol 400/propylene glycol
Active Comparator group
Description:
The other eye will receive a single instillation of one drop of an artificial tear with propylene glycol (0.3%) and polyethylene glycol (0.4%) as active ingredients with hydroxypropyl-guar as a gelling agent.
Treatment:
Drug: polyethylene glycol 400/propylene glycol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems